Systems-Level Theoretical Model

Kitzerow’s Autism and the Comorbidities Cascade

A systems-level theoretical model proposing how diverse genetic and epigenetic inputs can reprioritize biological resources toward the stress response. Through the BH4 Shunt, this reallocation redirects pathways across interconnected systems, affecting neural development and systemic function and producing distinct clusters of autism and comorbid traits.

Explore the Model Understand the Science

Kitzerow’s Autism and the Comorbidities Theory flow chart — Select the diagram to open its full accessibility description.

Start Here Foundational Knowledge and Key Terms Definitions needed to understand how the Cascade is organized

Biochemical Cascade

A connected series of biological events in which a change in one component influences other pathways, systems, or outcomes. A cascade can include branches, feedback loops, compensation, reinforcement, and inhibition.

Node

A measurable biological component or state within the Cascade. A node may be a gene-regulated protein, pathway, regulatory system, circuit state, physiological process, or trait outcome.

Relationship Between Nodes

The biological connection through which one node influences, constrains, regulates, or responds to another. These relationships are not assumed to be strictly one-way.

Homeostasis

The regulation of biological conditions around functional setpoints so the body can maintain relative stability while conditions change.

Allostasis

The process of changing biological activity and resource use to meet anticipated or ongoing demands. Allostasis is adaptive when the response resolves and regulation returns toward its usual range.

Chronic Allostasis

A sustained or repeatedly reactivated allostatic state in which biological resources remain prioritized around managing demand rather than returning fully to typical regulation.

Allostatic Load and Overload

Allostatic load is the accumulating biological cost of repeated adaptation. Allostatic overload occurs when demand exceeds the capacity of interconnected systems to compensate effectively.

Biochemical Shunt

A change in pathway use that redirects substrates, cofactors, or activity toward some biological functions and away from others.

Biological Resource Allocation

How limited substrates, cofactors, energy, protein activity, and regulatory capacity are distributed among competing biological demands.

Regulatory System Domain

One of the interconnected systems that detects deviation and coordinates a response. The model groups these into Immune System, Metabolism, Cellular Repair, Nervous System, and Genetic Regulation domains.

Temporal System Domain

The timing structure within which regulation occurs, including Ultradian, Circadian, Circannual, Developmental, and Aging patterns.

Biomarker

A measurable biological feature used to evaluate whether a proposed node or relationship is present.

Phenotype and Trait Cluster

The observable combination of autism traits and comorbid traits associated with an individual biological pattern.

How the Cascade Was Developed

From Initial Question to Testable Model

The Original Hypothesis

Observation: Kitzerow’s nonverbal autistic daughter could not blow out a candle on her birthday cake, leading to the realization that autism and the comorbidities, including nonverbality, are physiologically linked rather than independent traits.

Exclusivity Principle: It is biologically implausible for autism traits and comorbid traits to co-occur systematically in each phenotype without a shared biochemical root mechanism. Kitzerow hypothesized that differences in biochemical pathway activity across phenotypes drive both autism traits and predictable comorbidity patterns.

Source: BioToggle and BioDial Categorical Delineation, Methods, Steps 1 and 3

↓

How It Was Tested

Research: Kitzerow synthesized existing autism research and gene-coded protein-level biological data to understand how autism traits and comorbidities systematically co-occur across phenotypes.

Testing methodology: Computational systems analysis via biochemical network construction of gene-coded proteins and comparative analysis of autism-associated biomarkers against the network.

Data analysis: Identify patterns of convergence across biomarkers and trace the biochemical cascades that plausibly account for the observed associations.

Source: BioToggle and BioDial Categorical Delineation, Methods, Steps 2, 4, and 5

↓

The Resulting Theoretical Model

Autism arises from gene mutations and epigenetic factors that alter regulatory system behavior and constrain neural development and function. Comorbidities arise when stress-responsive BioToggle activation reallocates proteins via epigenetic, redox-sensitive BH4 shunt trifurcation, producing predictable autism traits via AAAH Shunt induced transamination pathway upregulation resulting in E/I imbalance in the CSTL and dysregulated neural development.

Simultaneously, this results in comorbidity clusters shaped by type, timing, and duration of regulatory system activation, with sustained activation increasing cumulative physiological impact via allostatic overload.

Source: BioToggle and BioDial Categorical Delineation, Methods, Step 6

What the Cascade Is and What It Predicts

The Full Theoretical Model

The Cascade is a systems-level map of how varied upstream biological inputs may converge on chronic allostatic regulation, alter BH4-dependent resource allocation, and produce different downstream neural and systemic effects.

The Cascade is not a strictly one-way pathway. Its organizing structure includes branching pathways, feedback loops, compensation, reinforcement, and inhibition. Individuals may also have different most-upstream identifiable nodes.

The central prediction is biological traceability. When an active node is identified, its connected biomarker pattern and associated trait outcomes should remain interpretable within the relationships proposed by the Cascade.

Different genetic and epigenetic inputs can affect shared regulatory architecture.
Chronic allostatic demand can change how biological resources are allocated.
BH4-dependent pathways can be affected differently according to competing biological demands.
Neural-development effects can produce distinguishable clusters of autism traits.
Systemic regulatory effects can produce distinguishable clusters of comorbid traits.
The systems involved, timing, duration, feedback, and magnitude of dysregulation can shape the individual phenotype.

What Is Novel?

Connecting Biochemical Shunts Into One System

Kitzerow identifies the BH4 Shunt and its role in the integrated Cascade as her novel contribution: a proposed mechanism connecting biochemical resource reallocation to autism-specific traits and biochemically linked comorbidities.

The Proposed BH4 Shunt Mechanism

In Kitzerow’s model, BH4 diversion and AAAH shunting drive transamination pathway upregulation, changing glutamate synthesis and resource allocation. The resulting dysregulation of excitation/inhibition balance in cortico-striatal-thalamo-limbic (CSTL) circuitry affects neural development and function, contributing to autism-specific traits involving movement, habit formation, reward and skill/behavior development. Where excessive excitation produces excitotoxic damage, the model also proposes regression.

Through the wider AAAH, NOS and AGMO branches and downstream protein shunts, the same resource-reallocation framework connects these nervous-system outcomes with comorbid traits across interconnected immune, metabolic, cellular repair and genetic regulation systems. This is not a uniform-deficit model: local availability and activity can increase or decrease according to demand, location and timing.

Metabolic Shunting

Under threat, biochemical activity shifts away from typical homeostatic pathways toward alternative allostatic pathways as resources are reallocated according to need. The framework draws on existing shunt biology, including the HMP shunt and glycogen shunt.

System-Wide Shunting

The Cascade proposes that allostatic demand coordinates resource reallocation through the BH4 Shunt and interacting downstream pathways, linking biochemical changes across the brain and body rather than treating every trait as an independent event.

Genes → Proteins → Pathways

Genetic and epigenetic conditions affect which proteins and isoforms are active and how effectively they function. The model follows those changes through pathway activity, cells, tissues and circuits to physiological traits.

Timing Shapes the Traits

Which regulatory domains are active, which temporal domains are disrupted, activation conditions, developmental stage, duration and strength shape the resulting pattern. Cumulative load and overload can add physiological wear over time.

Kitzerow’s account of the contribution: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities; Neurodivergent Biochemistry and the Autism and the Comorbidities Theory. These papers describe the proposed model; attribution of the contribution does not establish every causal connection or independently verify scientific priority.

See How the Cascade Works → See How the Model Was Created → Track the Evidence →

Functional Biochemical Model

Explore Kitzerow's Autism and the Comorbidities Cascade

Model explanation How the Cascade Produces Physiological Traits

Kitzerow’s Cascade proposes the biological sequences that produce specific autism and comorbid traits. It follows how regulatory demand changes resource allocation, how that changes protein and pathway function, and how those molecular changes reach cells, tissues, organs and neural circuits to produce an observable physiological trait.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities; Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

A cascade of shunts and resource reallocation, not just deficits. In this model, every node can have higher or lower availability or functional activity according to where biochemical resources are allocated in the body and what is needed at a given time. Precursors can be redirected into alternative pathways. Increased production, increased use and increased local availability are not interchangeable: a resource can be prioritized in one tissue or pathway while becoming less available elsewhere. Location, demand, timing, feedback and clearance shape the physiological outcome. Specific increases or decreases shown below describe particular routes, not a fixed state for every person.

Two connected outcome cascades: the model links autism-trait clusters to BH4-shunt effects on neural-circuit development through E/I imbalance and mTOR signaling differences, and on CSTL function through neurotransmitter imbalance. Comorbid-trait patterns arise through the interconnected biological systems affected alongside those neural circuits.

The model extends beyond DNA → RNA → protein by following:

gene → protein/isoform → functional efficacy → physiological impact → symptom/trait

Every branch should preserve these categories of functional causation:

Initiating State Genetically Locked, Epigenetically Stuck, or Situationally Flipped
Regulatory State Set point deviation → regulatory demand → homeostasis vs allostasis
Resource Flow BioToggle demand → BioDial timing/disruption → biochemical resource reallocation
Biochemical Shunting BH4 Shunt → AAAH, NOS, or AGMO → downstream protein/pathway shunting
Functional Impact Molecular function → cellular function → tissue, organ, or neural circuit function
Physiological Outcome Physiological change → functional change → specific trait or comorbidity.

Not every autistic person will have every autism or comorbid trait shown here. Each individual’s unique entry point and interacting variables shape which routes become active and what outcomes follow. These include the affected proteins and their functional capacity, the active BioToggle and BioDial, resource availability, the direction and magnitude of pathway changes, developmental timing, duration, feedback, compensation and cumulative allostatic load.

The model does not require every person to begin at the top, pass through every node or share the same biomarker pattern. A downstream entry point can affect its connected routes without requiring every upstream change. Open a route to trace its proposed physiology, including the intervening steps and the limits of the evidence.

↓ Synthesis or a stated downstream effect ↳ A branch, not the next synthesis step ↔ Interaction or feedback + Mechanism, complete route and sources

Regulatory context

Entry point, resource demand and timing

What Are the Entry Points?

The model distinguishes three conditions that create or sustain regulatory demand. An individual’s most upstream affected node and downstream resource needs shape the route that follows.

Why the state persists Genetically Locked

Genetic variant
altered gene coded protein
altered protein function or functional efficacy
altered biochemical pathway activity
altered regulatory feedback
set point cannot be maintained or efficiently restored
compensatory pathway activity remains necessary
system is genetically locked into the allostatic state

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

Why the state persists Epigenetically Stuck

initial threat
appropriate allostatic response
altered biochemical and redox environment
altered epigenetic regulation
altered protein expression, isoforms, modification or activity
stress responsive pathways remain favored
regulatory set point is not completely restored
continued allostatic resource allocation
the altered state reinforces itself
system becomes epigenetically stuck

Chronicity describes persistence of this state, not a fourth initiating category.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

Adaptive temporary state Situationally Flipped

situational threat
sensor detects deviation from set point
regulatory controller responds
allostasis is activated
resources are temporarily reprioritized
threat is addressed
feedback indicates that the set point has been restored
allostatic program resolves
typical homeostatic resource flow resumes.

If the response becomes epigenetically maintained, it can become stuck rather than remaining a transient response.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

Homeostasis, Allostasis and Regulatory Control

Each regulatory system domain uses a control architecture to maintain balance or respond to changing demand.

Maintaining balance and responding to demand Homeostasis, Allostasis and the Five Regulatory Components

Homeostasis · Maintaining Baseline

BioDial timing
expected proteins are induced at the expected time
expected pathways receive their substrates and cofactors
resources flow toward the biological functions scheduled for that period
regulatory feedback maintains physiological variables around their set points
baseline is maintained

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory; Genomic and Proteomic Regulation in Cellular Homeostasis.

Allostasis · Restoring Balance

threat
set point deviation
sensor detects error
controller activates compensatory response
biological priorities change
resources are redirected toward resolving the threat
allostasis

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory; Genomic and Proteomic Regulation in Cellular Homeostasis.

Set Point, Sensor, Error Detector, Controller and Effector

The source defines the shared regulatory architecture below. Its glucose example illustrates the architecture; it does not assign the same sensor or controller to every BioToggle.

Set point: Optimal value or range for physiological parameters, such as temperature, pH or metabolite levels.
Sensor: Detects changes in physiological parameters. Source example: pancreatic beta cells detect blood glucose levels.
Error detector: Compares sensor data with the set point and identifies deviations. Source example: ATP-sensitive potassium channels in beta cells.
Controller: Processes information from the error detector and signals effectors. Source example: pancreatic beta cells signaling insulin release.
Effector: Executes corrective actions to return toward the set point. Source example: insulin release to lower blood glucose.

Source: BioToggle: The Allostatic Toggles Framework, Regulatory System panel. The domain cards below retain the framework’s triggers, responses and restoration conditions.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

This five-component architecture is the shared framework for the immune, metabolic, cellular repair, nervous-system and genetic regulation domains. The regulated variable, sensors, signaling and effectors depend on the domain; the glucose example is not a component assignment for every system. Domain-specific activation and restoration conditions appear under Resource Reallocation below.

Resource Reallocation

BioToggles identify where regulatory resources are required. BioDials describe when those resources are needed for function, development and repair.

Where demand occurs and when resources are needed BioToggle Regulatory Domains and BioDial Temporal Domains

BioToggles · Regulatory System Domains

Each domain has its own activation and restoration conditions. These describe the conceptual framework, not diagnostic thresholds or treatment instructions.

BioToggle #1 · Regulatory domain Immune System

Restoration target: Pathogen clearance and clearance of pathogen-associated molecular patterns (PAMPs) and antigens.
What toggles it on: PAMPs activate pattern recognition receptors (PRRs) on innate immune cells. Antigens are recognized directly by B cells or presented to T cells via major histocompatibility complex (MHC) molecules.
What it activates: Innate activation leads to cytokine release, inflammation, and recruitment of neutrophils and macrophages. Adaptive activation leads to B-cell-mediated antibody production, CD4+ T-cell coordination, and CD8+ T-cell cytotoxic activity.
What toggles it off: Pathogens, PAMPs and antigens are cleared.

Resource priority in the cascade: Immune defense, cytokine and inflammatory signaling, pathogen response, immune protein synthesis and resolution.

Source: BioToggle: The Allostatic Toggles Framework, Toggle #1. Restoration target summarizes the source’s off-condition; it is not a numerical clinical set point.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

BioToggle #2 · Regulatory domain Metabolism · Metabolites (+/−)

Restoration target: Balanced levels of essential metabolites, including glucose, ATP and amino acids.
What toggles it on: Imbalances in essential metabolites such as glucose, ATP or amino acids due to poor diet, malabsorption or metabolic disorders.
What it activates: Macrophage M1/M2 polarization, nutrient-sensing pathways such as AMPK and mTOR, and transcription factors such as NF-κB and FoxO.
What toggles it off: Balanced metabolite levels are achieved.

Resource priority in the cascade: Substrate utilization, ATP production, mitochondrial activity, glucose regulation, amino-acid and lipid metabolism, and redox support.

Source: BioToggle: The Allostatic Toggles Framework, Toggle #2. Restoration target summarizes the source’s off-condition; it is not a numerical clinical set point.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

BioToggle #3 · Regulatory domain Cellular Repair

Restoration target: Completed cellular repair, including wound closure, tissue regeneration and collagen deposition, with resolution of inflammation.
What toggles it on: Mechanical damage such as tissue injury, stretching or a barrier breach, and damage-associated molecular patterns (DAMPs) released from damaged cells.
What it activates: DAMPs activate tissue repair through inflammasome signaling, local inflammation, recruitment of macrophages and fibroblasts, and pathways involved in wound healing, cellular debris clearance and extracellular matrix remodeling.
What toggles it off: Cellular repair is completed and inflammation resolves.

Resource priority in the cascade: Autophagy, lysosomal clearance, extracellular matrix remodeling, wound response, structural protein turnover, and damaged organelle removal.

Source: BioToggle: The Allostatic Toggles Framework, Toggle #3. Restoration target summarizes the source’s off-condition; it is not a numerical clinical set point.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

BioToggle #4 · Regulatory domain Nervous System

Restoration target: Restored autonomic balance, resolved perceived threat, cortisol levels within the typical range, reconnection to safety signals, and neuroplastic reintegration of disrupted circuits.
What toggles it on: Perceived psychological or environmental threat, emotional trauma, sensory overload or loss of safety cues. The framework describes HPA-axis engagement and autonomic dysregulation, often through sympathetic overactivation and/or parasympathetic withdrawal.
What it activates: Altered autonomic function, including increased heart rate and disrupted digestion; heightened vigilance; cortisol and adrenaline release; disrupted neurotransmitter balance, such as elevated glutamate and reduced GABA; impaired prefrontal cortex regulation; and reduced neuroplasticity.
What toggles it off: Restoration of autonomic balance through parasympathetic activation, resolution of the perceived threat, cortisol levels within the typical range, reconnection to safety signals, and neuroplastic reintegration of disrupted circuits.

Resource priority in the cascade: Autonomic regulation, sensory processing, threat response, neurotransmission, excitability, movement, attention, reward and neural plasticity.

Source: BioToggle: The Allostatic Toggles Framework, Toggle #4. Restoration target summarizes the source’s off-condition; it is not a numerical clinical set point.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

BioToggle #5 · Regulatory domain Epigenetic/Genetic Protein Synthesis

Restoration target: Stress signals have resolved and protein needs are met, while baseline synthesis continues under homeostatic regulation.
What toggles it on: Internal stress signals from the immune, metabolic, cellular repair and nervous system toggles trigger adaptive gene expression and epigenetic production of allostatic proteins. The framework also describes continuous circadian regulation of baseline protein synthesis and biochemical flow-state.
What it activates: Transcription, epigenetic changes and protein synthesis, producing adaptive isoforms, stress-response proteins, and essential structural and functional proteins.
What toggles it off: The stress-related response toggles off when stress signals resolve and protein needs are met. Baseline protein synthesis continues under homeostatic regulation.

Resource priority in the cascade: Transcription, alternative splicing, isoform selection, translation, post-translational modification, localization, stability, degradation and functional activity.

Source: BioToggle: The Allostatic Toggles Framework, Toggle #5. Restoration target summarizes the source’s off-condition; it is not a numerical clinical set point.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory; Genomic and Proteomic Regulation in Cellular Homeostasis.

BioDials · Temporal System Domains

Temporal resource demand Ultradian

Repeated short-cycle physiological processes

During allostasis, the consequence depends on which scheduled process competes for resources with the active BioToggle.

Temporal-framework source: BioToggle and BioDial Categorical Delineation. The supplied version describes the BioDial framework but does not separately outline this ultradian node.

Temporal resource demand Circadian

Clock-regulated protein induction, SCN entrainment, sleep-wake, hormonal, immune, metabolic and autonomic rhythms

During allostasis, the consequence depends on which scheduled process competes for resources with the active BioToggle.

Paper outlining this node: BioToggle and BioDial Categorical Delineation.

Temporal resource demand Circannual

Seasonally coordinated immune, metabolic, endocrine, behavioral and environmental protein programs

During allostasis, the consequence depends on which scheduled process competes for resources with the active BioToggle.

Paper outlining this node: BioToggle and BioDial Categorical Delineation.

Temporal resource demand Developmental

Growth, organ construction, neuronal migration, axon guidance, synapses, myelination, motor, language, cognitive and social-emotional development

During allostasis, the consequence depends on which scheduled process competes for resources with the active BioToggle.

Paper outlining this node: BioToggle and BioDial Categorical Delineation.

Temporal resource demand Aging

Maintenance, turnover, mitochondrial function, autophagy, lysosomal clearance, DNA repair, ECM integrity and regeneration

During allostasis, the consequence depends on which scheduled process competes for resources with the active BioToggle.

Paper outlining this node: BioToggle and BioDial Categorical Delineation.

Resource demand and timing interact ↓

Resource Competition and Temporal Displacement

Proposed causal route Disrupted BioDial Resource Flow

The active stress response competes with biological programs already scheduled by the BioDials. Outcomes depend on resource diversion, substrate competition, protein reprioritization, timing and developmental window.

Allostatic priority
resources redirected toward the active BioToggle
less, delayed or differently routed supply to a concurrently active BioDial program
altered protein efficacy and pathway throughput
tissue-specific functional consequences

Paper outlining this node: BioToggle and BioDial Categorical Delineation.

BH4 Resource Reallocation

The pathway cards below belong to this shared allocation hub. Explore precursor redirection, catecholamine and serotonin pathways, nitric-oxide/redox signaling and ether-lipid metabolism within the same BH4 resource-reallocation framework.

Shared biochemical allocation hub BH4 Shunt

Reallocates BH4-dependent and upstream metabolic resources under allostatic demand. The three interacting arms affect aromatic amino-acid metabolism, nitric-oxide and redox regulation, and ether-lipid catabolism.

Protein abundance is not equivalent to functional efficacy. Cofactors, substrates, redox environment, interacting proteins, isoforms, modifications and metabolic flux all matter.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities; Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

Biochemical pathways

One full-width card per pathway. Shared allocation, separate routes.

AAAH Shunt: Precursor Redirection and Upstream Effects

AAAH · Precursor allocation

The AAAH shunt is not only a change in downstream neurotransmitter synthesis. The model also follows the upstream precursor pools and alternative pathways affected when aromatic amino-acid hydroxylation changes: phenylalanine metabolism, transamination and glutamate synthesis, glutathione demand, and competing tryptophan metabolism.

Phenylalanine alternatives
Transamination / glutamate
Related circuit modulation

Additional context · Autism and comorbid traits Pathway-Level Trait Overview

Proposed Trait Connections

Autism-trait connections: Proposed autism-trait route: transamination upregulation changes glutamate synthesis and allocation between glutathione, excitatory transmission and GABA synthesis. CSTL excitation/inhibition imbalance alters the formation and activity of circuits supporting movement, habit formation, reward and learned skills or behaviors. The model links this to repetitive behavior, differences in skill/behavior development and, where excitotoxic injury occurs, regression. Different circuit states can produce hyperactivity or hypoactivity rather than one uniform outcome.
Comorbid-trait connections: Proposed comorbid routes: precursor and neurotransmitter reallocation affects mood, motivation, reward, emotional regulation and stress response. Glutamate-related peripheral signaling also connects to pain and mast-cell-associated effects. Phenylpyruvate-related energy/redox effects and phenylacetate-related nitrogen disposal are biochemical branches; these do not yet establish a specific autism or comorbid trait.

Phenylalanine not converted into tyrosine can enter typically minor alternative metabolic routes producing phenylpyruvate, phenylethylamine and phenylacetate. These are branching routes, not a single sequence through all three metabolites.

Phenylalanine: PAH Conversion and Alternative Routes

Phenylalanine → Tyrosine PAH · Phenylalanine Hydroxylase

BH4-dependent PAH links upstream phenylalanine handling to downstream tyrosine availability. The model places this conversion within demand-dependent resource allocation, including diversion toward alternative amino-acid pathways. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand PAH branch Proposed outcome: neural and autonomic functions dependent on those catecholamines can change.

BH4 Shunt
reduced or altered BH4 allocation to phenylalanine hydroxylase, PAH
PAH-mediated phenylalanine
tyrosine conversion changes
phenylalanine handling changes and tyrosine substrate availability changes
less or altered tyrosine is available upstream of tyrosine hydroxylase
downstream catecholamine synthesis can change
dopamine, norepinephrine, and epinephrine availability can subsequently change
neural and autonomic functions dependent on those catecholamines can change.

Your sources develop this primarily as an upstream substrate-allocation mechanism rather than tying PAH itself to one specific outward autism trait.

Shunt context: this route describes a particular allocation state, not a permanently high or low node. In the model, local availability or activity depends on where resources are directed, current demand and timing. The opposite state requires its own mechanism; it does not automatically reverse every trait listed here.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Phenylalanine Hydroxylase. Working reference: Cascade Logic, route A. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Phenylalanine not converted to tyrosine → alternative metabolism

Alternative Products and Their Downstream Effects

Alternate phenylalanine route · Transamination Phenylpyruvate · Cellular Energy and Redox Balance

Phenylalanine can undergo transamination to phenylpyruvate rather than PAH-dependent conversion to tyrosine.

Glucose-6-phosphate dehydrogenase

Phenylpyruvate
reduced G6PD activity observed in rat brain homogenates
potentially reduced NADPH production
possible impairment of glutathione recycling and antioxidant defense

Mitochondrial pyruvate transport

Phenylpyruvate
inhibition of mitochondrial pyruvate transport in experimental preparations
reduced pyruvate oxidation
potential disruption of cellular energy supply

These are experimental biochemical effects, not established autism-specific trait outcomes. Their relevance depends on the concentrations and tissues involved. The mitochondrial study found transport inhibition, not inhibition of pyruvate dehydrogenase.

Added biochemical sources: Rosa et al., 2012: phenylpyruvate and G6PD; Halestrap et al., 1974: mitochondrial pyruvate transport.

Alternate phenylalanine route · Decarboxylation Phenylethylamine · Trace-Amine Signaling and Clearance

Phenylalanine can also undergo decarboxylation to beta-phenylethylamine (PEA), a trace amine neuromodulator with stimulant effects. This is a separate branch, not a product downstream of phenylpyruvate.

TAAR1 and monoamine transport

Phenylalanine
decarboxylation
phenylethylamine
TAAR1 activation and altered monoamine transporter function
dopamine and norepinephrine efflux with inhibited uptake in experimental cell and synaptosome systems

These findings concern release and transport of existing monoamines, not conversion of phenylethylamine into dopamine or norepinephrine. The net circuit effect cannot be reduced to a universal increase in either transmitter.

MAO-B clearance

Phenylethylamine
MAO-B-mediated oxidative deamination
phenylacetaldehyde
further oxidation to phenylacetate

PEA is typically rapidly metabolized. MAO-B activity, production rate and tissue context influence its availability and duration of action.

A specific autism or comorbid trait does not follow from PEA elevation alone. Connecting this branch to an individual trait requires measurements of exposure, clearance and the relevant circuit.

Added biochemical sources: Xie and Miller, 2008: TAAR1-dependent uptake and efflux; Bortolato et al., 2009: MAO-B and PEA; Wu and Boulton, 1975: rapid PEA metabolism in rats.

Downstream convergence · Nitrogen disposal Phenylacetate · Glutamine Conjugation and Nitrogen Disposal

Phenylacetate is a downstream metabolite of alternative phenylalanine metabolism, including PEA breakdown. Conjugation requires activation to phenylacetyl-CoA before transfer to glutamine.

Phenylacetate + CoA + ATP
phenylacetyl-CoA
glutamine N-phenylacetyltransferase activity with L-glutamine
phenylacetylglutamine
urinary excretion of glutamine-derived nitrogen

The acyl-transfer step is glutamine N-phenylacetyltransferase activity, also described as glutamine N-acyltransferase, rather than a direct acetylation of glutamine by free phenylacetate.

This identifies a glutamine-consuming disposal route. It does not establish that endogenous phenylacetate causes systemic glutamine depletion or a particular trait. Those predictions require flux, concentration and excretion measurements.

Added biochemical sources: Reactome: phenylacetate activation and glutamine conjugation; Human GLYATL1 enzymatic validation, 2023.

Alternative route overview: Kaufman, 1999: human phenylalanine metabolism. These minor routes can operate alongside hydroxylation; reduced tyrosine conversion does not mean all phenylalanine enters them.

Transamination Upregulation: Glutamate Synthesis and CSTL Effects

The model proposes this connected sequence: AAAH precursor redirection → transamination upregulation → increased glutamate synthesis and altered allocation → glutathione demand and changes in glutamate/GABA balance → CSTL dysregulation → circuit-specific physiological traits. Feedback and competing resource demands determine the direction and magnitude of each outcome.

Proposed precursor redirection under allostatic demand Transamination Upregulation → Increased Glutamate Synthesis

The model proposes that the AAAH shunt favors aminotransferase/transamination pathways, increasing glutamate synthesis to support glutathione production under oxidative demand. Increased production is not equivalent to increased synaptic glutamate: allocation to antioxidant defense, GABA synthesis, transport and clearance determine local availability. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities.

Mechanism and source · expand AAAH Shunt → transamination → glutamate → glutathione Proposed outcome: this branch feeds both the redox-defense pathway and the E/I imbalance pathway.

BH4 Shunt
oxidative/allostatic demand
AAAH resources are diverted away from typical aromatic-amino-acid hydroxylation
aminotransferase / transamination pathways become relatively favored
glutamate production changes
glutamate is directed toward glutathione synthesis
antioxidant capacity is supported
resources are preferentially allocated toward redox defense
less glutamate is available for or appropriately balanced across its other neural functions
this branch feeds both the redox-defense pathway and the E/I imbalance pathway.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: AAAH shunt, transamination and CSTL circuitry. Working reference: Cascade Logic, route N. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Proposed neural-circuit and physiological consequences Glutamate Allocation → GABA Balance → CSTL E/I Imbalance and Regression

Changed glutamate allocation alters excitatory signaling and the supply for GABA synthesis. The model links the resulting excitation/inhibition imbalance to altered firing thresholds and network stability in cortico-striatal-thalamo-limbic (CSTL) circuitry. Movement, habit formation, reward, cognition and behavioral regulation can be affected, with repetitive behavior, hyperactivity, motor differences, cognitive suppression or hyperexcitation depending on local circuit state. Where excessive excitation produces excitotoxic synaptic or neuronal damage, the model proposes deterioration of circuits supporting previously acquired skills and behaviors, leading to regression. Functional E/I imbalance does not necessarily produce damage or regression. The PFC and peripheral immune-cell routes remain separate branches. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities.

Mechanism and source · expand Glutamate → GABA balance → CSTL E/I balance Proposed outcome: repetitive behavior, hyperactivity, motor differences, cognitive suppression or hyperexcitation, depending on direction and local circuit state. The model also proposes excitotoxicity-induced regression when damage impairs circuits supporting previously acquired skills or behaviors.

AAAH/transamination shift
glutamate availability changes
glutamate availability for excitatory transmission changes
glutamate availability as precursor for GABA synthesis changes
glutamate:GABA relationship changes
excitatory/inhibitory balance changes
neuronal firing thresholds and network stability change
cortico-striatal-thalamo-limbic circuitry becomes dysregulated
movement, habit formation, reward, cognition, and behavioral regulation change
repetitive behavior, hyperactivity, motor differences, cognitive suppression or hyperexcitation, depending on direction and local circuit state.

Proposed regression connection: where excitotoxic damage affects circuits supporting an acquired skill or behavior, the model predicts loss or reduced expression of that previously acquired function. This is a proposed route to regression, not a claim that every E/I imbalance causes neuronal damage or that all regression has this cause.

AAAH-associated glutamate reallocation and E/I imbalance
excessive glutamate-receptor activation where local excitation exceeds regulation
intracellular calcium loading and excitotoxic stress
synaptic or neuronal damage in affected CSTL circuits
impaired circuit function
loss or reduced expression of previously acquired skills or behaviors
proposed regression

Connected excitotoxicity mechanism: Autism & the Comorbidities Along the BH4 Pathway. See the combined AAAH/NOS excitotoxicity route and its source boundaries.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: AAAH shunt, transamination and CSTL circuitry. Working reference: Cascade Logic, route O. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand Glutamate → OXTR+ PFC neurons → PFC-amygdala circuit Proposed outcome: social-recognition difficulties, social-communication impairment, altered social behavior, impaired social memory.

BH4/AAAH dysfunction
glutamate elevation/dysregulation
excessive glutamatergic stimulation
excitotoxic stress
damage or functional impairment of glutamatergic prefrontal-cortical neurons expressing oxytocin receptors, OXTRs
altered signaling within the oxytocin-sensitive PFC-amygdala circuit
impaired social-recognition processing
reduced oxytocin-mediated social cognition, social memory, and social behavior
social-recognition difficulties, social-communication impairment, altered social behavior, impaired social memory.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Low Oxytocin; Autism Social Symptoms. Working reference: Cascade Logic, route Q. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand Glutamate → peripheral immune cells → PLC/Ca²⁺/PKCε/TRP → pain Proposed outcome: pain hypersensitivity, chronic pain, nociceptive sensitization.

Glutamate dysregulation
glutamate release by macrophages, mast cells, and dendritic cells in peripheral tissues
uptake/transport through EAATs
peripheral glutamate-receptor activation
phospholipase C, PLC, activation
intracellular Ca²⁺ release
PKCε activation
TRP ion-channel activation in peripheral sensory pathways
increased nociceptor activation
amplified peripheral sensory signaling
pain hypersensitivity, chronic pain, nociceptive sensitization.

With mast-cell hyperactivity, increased glutamate release can amplify this pathway and contribute to MCAS-associated pain.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Chronic Pain. Working reference: Cascade Logic, route T. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Related Modulation: KYNA and Oxytocin-Sensitive Signaling

Alternative tryptophan route KYNA

Kynurenic acid changes antagonism of glutamate and alpha-7 nicotinic acetylcholine receptors. The source distinguishes increased from reduced inhibition. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand KYNA → glutamate receptors / α7nAChR → CST loop Proposed outcome: motor differences or hyperactivity.

Tryptophan metabolism
kynurenic acid, KYNA, changes
KYNA antagonism of glutamate receptors and α7 nicotinic acetylcholine receptors, α7nAChRs, changes
if KYNA is elevated, glutamate signaling is suppressed
CST loop activity can become underactive
motor and cognitive suppression / hypoactivity

Alternative direction

if KYNA is reduced, glutamate receptor inhibition decreases
excitatory glutamate signaling increases
CST loop hyperexcitation increases
motor differences or hyperactivity.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Kynurenic Acid and Glutamate Imbalance. Working reference: Cascade Logic, route P. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Social and compensatory sensory branches Oxytocin-sensitive signaling

These routes connect the oxytocin-sensitive social circuitry with attachment and the source’s proposed compensatory sensory interpretation. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand Oxytocin → CA/OXT neuron receptor interactions → pair bonding Proposed outcome: social behavior, pair bonding, and interpersonal connection can be altered.

BH4/neurotransmitter dysregulation
oxytocin regulation changes
catecholamine/oxytocin volume transmission and receptor-receptor interactions in CA/OXT neurons change
neural signaling supporting interpersonal social attachment changes
social behavior, pair bonding, and interpersonal connection can be altered.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Low Oxytocin; Autism Social Symptoms. Working reference: Cascade Logic, route R. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand Oxytocin → sensory input → stress regulation Proposed outcome: sensory-seeking behavior is proposed in the older paper as a possible compensatory strategy for stress/anxiety reduction.

Reduced or altered oxytocin signaling
touch, stroking, and warm-temperature sensory input can stimulate oxytocin release
sensory behavior may become functionally recruited to increase oxytocin and reduce stress
sensory-seeking behavior is proposed in the older paper as a possible compensatory strategy for stress/anxiety reduction.

This remains a hypothesis-level behavioral interpretation in the source.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Low Oxytocin; Autism Social Symptoms. Working reference: Cascade Logic, route S. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

TH · Tyrosine Hydroxylase Pathway

AAAH · Catecholamine synthesis

Follow synthesis down the node lane. Each neurotransmitter branches into its own physiological routes.

Tyrosine
L-DOPA
Dopamine
Norepinephrine
Epinephrine

Additional context · Autism and comorbid traits Pathway-Level Trait Overview

Proposed Trait Connections

Autism-trait connections: Within the proposed autism-trait cascade, dopamine-dependent dorsal-striatal, ventral-striatal and CST routes affect movement, habit/repetition, reward, cognition and behavioral regulation. The source describes differing outcomes with local pathway balance, including motor differences, hyperactivity, hypoactivity and repetitive behavior.
Comorbid-trait connections: Catecholamine reallocation contributes to the proposed mental-health cluster through changes in mood, motivation, reward and stress response. Separate dopamine pain routes and norepinephrine sympathetic/renal routes connect to pain processing and autonomic effects. The POTS/orthostatic-intolerance route combines catecholamine changes with NOS/vascular and RAAS changes, rather than attributing it to norepinephrine alone.

Each node is followed by its mechanisms and visible trait or physiological outcomes. Open “Full mechanism and source” for the detailed sequence.

Related model · Catecholamine shunts

ADHD · Dopamine, Norepinephrine and Epinephrine

Kitzerow’s BH4-pathway paper places ADHD in its catecholamine discussion. The relevant nodes are dopamine, norepinephrine and epinephrine, including their production, distribution, receptors and clearance.

Mechanism and source How the paper connects these nodes to ADHD

The paper’s ADHD section links catecholamine dysregulation to inattention, impulsivity and hyperactivity. It discusses BH4-dependent synthesis alongside receptor and transporter function, not a single universal dopamine deficit.

Its dopamine-transporter example describes reduced clearance and excess dopamine in animals lacking DAT. This illustrates why local signaling can be high as well as low; it does not establish that every person with ADHD has that alteration.

Within the Cascade model, resource allocation and synthesis interact with location, receptor response and clearance. A specific ADHD phenotype requires its own supported connection between the measured state and the trait.

Source: Autism & the Comorbidities Along the BH4 Pathway, ADHD section.

Proposed trait connections

Inattention, impulsivity and hyperactivity, with expression depending on the affected signaling pathways and circuits.

Explore Kitzerow’s ADHD Model →

BH4-dependent synthesis and resource allocation Tyrosine–Dopamine

Tyrosine enters the TH-dependent route toward L-DOPA, while competing amino-acid reactions can redirect precursor use. TH (tyrosine hydroxylase) converts tyrosine to L-DOPA. Its functional efficacy and available cofactors influence catecholamine synthesis. L-DOPA is converted to dopamine through aromatic L-amino-acid decarboxylase. This preserves the intervening synthesis step rather than connecting tyrosine directly to a trait. Dopamine acts in distinct cell populations and circuits and also supplies the norepinephrine synthesis route. Its effects depend on receptor activity, location, clearance and circuit state. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand TH → dopamine → dorsal striatum → motor output Proposed outcome: motor differences, altered movement initiation, altered movement inhibition, hyperactivity, akinesia, dystonia, ataxia, and broader motor impairment.

BH4 Shunt
AAAH Shunt
altered BH4 allocation to tyrosine hydroxylase, TH
altered tyrosine
L-DOPA conversion
altered dopamine synthesis
altered dopamine release and receptor signaling
altered activation of D1 receptor-expressing direct-pathway medium spiny neurons and D2 receptor-expressing indirect-pathway medium spiny neurons
altered direct versus indirect pathway balance in the dorsal striatum / cortico-striatal-thalamic loop
altered movement initiation versus inhibition
altered basal-ganglia motor selection
motor differences, altered movement initiation, altered movement inhibition, hyperactivity, akinesia, dystonia, ataxia, and broader motor impairment.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Dopamine Imbalance; Motor Impairments; CST loop. Working reference: Cascade Logic, route B. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand TH → dopamine → dorsal striatum → habit formation Proposed outcome: repetitive behavior / altered habit formation.

BH4 Shunt
AAAH Shunt
TH flux changes
L-DOPA changes
dopamine availability changes
dopaminergic modulation of the dorsal striatum changes
direct/indirect corticostriatal pathway weighting changes
action repetition and reinforcement thresholds change
habit stabilization changes
repeated motor or behavioral programs become differently reinforced
repetitive behavior / altered habit formation.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Dopamine Imbalance; Motor Impairments; CST loop. Working reference: Cascade Logic, route C. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand TH → dopamine → ventral striatum / nucleus accumbens → reward Proposed outcome: altered reward responsiveness, motivation, reinforcement learning, and related behavioral output.

BH4 Shunt
AAAH Shunt
TH-mediated catecholamine synthesis changes
dopamine availability changes
dopamine signaling within the ventral striatum / nucleus accumbens changes
D1/D2 medium spiny neuron activity changes
reward salience and reinforcement signaling change
reward-dependent learning, reinforcement learning, motivation, and action selection change
altered reward responsiveness, motivation, reinforcement learning, and related behavioral output.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Dopamine Imbalance; Motor Impairments; CST loop. Working reference: Cascade Logic, route D. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand TH → dopamine → CST loop → cognition and emotional regulation Proposed outcome: cognitive impairment, emotional dysregulation, difficulty experiencing pleasure, and executive-control differences.

BH4 Shunt
AAAH Shunt
TH flux changes
dopamine synthesis changes
dopamine modulation of the cortico-striatal-thalamic loop changes
integration of motor, cognitive, and emotional information changes
cognitive control and reward-based action selection change
cognitive impairment, emotional dysregulation, difficulty experiencing pleasure, and executive-control differences.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Dopamine Imbalance; Motor Impairments; CST loop. Working reference: Cascade Logic, route E. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand TH → dopamine → basal ganglia pain circuitry Proposed outcome: chronic pain / altered pain processing.

BH4 Shunt
AAAH Shunt
TH-dependent dopamine synthesis changes
dopamine availability in basal ganglia and associated pain-processing circuits changes
dopaminergic modulation of pain processing changes
central pain perception changes
chronic pain / altered pain processing.

The cited paper also notes that BH4 itself participates in pain biology through GCH1/SPR activity in damaged nerves, neurons, macrophages, inflamed tissue, and wound healing, so the pain phenotype is not reduced to dopamine alone.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Chronic Pain. Working reference: Cascade Logic, route F. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand COMT → catecholamine degradation → mood/behavior Proposed outcome: mood dysregulation and potentially aggressive behavior in the context discussed in the source.

Catecholamine state
metabolism through catechol-O-methyltransferase, COMT
methylation of dopamine, norepinephrine, and epinephrine changes according to COMT function
catecholamine clearance changes
synaptic catecholamine availability changes
mood-regulatory and behavioral circuits receive altered catecholaminergic input
mood dysregulation and potentially aggressive behavior in the context discussed in the source.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: COMT Gene Mutation. Working reference: Cascade Logic, route J. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Downstream catecholamine Norepinephrine

Dopamine beta-hydroxylase converts dopamine to norepinephrine. Central noradrenergic effects and peripheral sympathetic effects form different branches. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand TH → norepinephrine → central attention/arousal systems Proposed outcome: inattention, altered vigilance, hyperarousal, attentional dysregulation, fatigue or reduced alertness, depending on direction of the shift.

BH4 Shunt
AAAH Shunt
TH-mediated catecholamine synthesis changes
dopamine precursor availability changes
norepinephrine synthesis changes
noradrenergic modulation of central arousal and vigilance systems changes
attentional gain, vigilance, and response to salient stimuli change
inattention, altered vigilance, hyperarousal, attentional dysregulation, fatigue or reduced alertness, depending on direction of the shift.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Tyrosine Hydroxylase; Catecholamine Malfunctions and Mental Health Implications. Working reference: Cascade Logic, route G. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand TH → norepinephrine → sympathetic nervous system → RAAS Proposed outcome: convergence with the ACE2/NOS/POTS branch.

BH4 Shunt
AAAH Shunt
altered norepinephrine synthesis
altered sympathetic nervous-system signaling
altered adrenergic regulation of heart rate and vascular tone
altered β1-adrenergic stimulation of renal juxtaglomerular cells
altered renin release
altered renin-angiotensin-system activity
altered Angiotensin II load
increased vascular and redox demand
convergence with the ACE2/NOS/POTS branch.

This is the AAAH-to-autonomic bridge.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory. Section/topic: ACE2 Shunt: sympathetic activation, renin and orthostatic physiology. Working reference: Cascade Logic, route H. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Downstream catecholamine Epinephrine

PNMT converts norepinephrine to epinephrine. The source describes their joint effects on cardiovascular output, vascular tone, metabolic mobilization and systemic stress physiology. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand TH → norepinephrine / epinephrine → systemic stress physiology Proposed outcome: altered stress response, altered heart-rate regulation, altered blood-pressure regulation, fatigue, hyperarousal or autonomic instability.

BH4 Shunt
AAAH Shunt
catecholamine synthesis changes
norepinephrine and epinephrine signaling changes
autonomic and hormonal stress responses change
cardiovascular output, vascular tone, blood-pressure control, heart-rate regulation, and metabolic mobilization change
altered stress response, altered heart-rate regulation, altered blood-pressure regulation, fatigue, hyperarousal or autonomic instability.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Tyrosine Hydroxylase; Catecholamine Malfunctions and Mental Health Implications. Working reference: Cascade Logic, route I. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

TPH · Tryptophan Hydroxylase Pathway

AAAH · Serotonin and melatonin synthesis

Distinct affect-regulation, circadian and developmental routes branch from serotonin and melatonin.

Tryptophan
5-HTP
Serotonin
Melatonin

Additional context · Autism and comorbid traits Pathway-Level Trait Overview

Proposed Trait Connections

Autism-trait connections: The source links serotonin-derived melatonin to maternal/fetal entrainment and the timing of developmental gene expression and protein production. This is a proposed timing contribution to developmental outcomes, not a standalone assignment of one diagnostic autism trait to serotonin or melatonin.
Comorbid-trait connections: Serotonin routes involve affect and emotional regulation; SCN entrainment and melatonin routes involve circadian timing and sleep-related regulation. These are the proposed connections between this branch and emotional or sleep-related comorbid traits.

Each node is followed by its mechanisms and visible trait or physiological outcomes. Open “Full mechanism and source” for the detailed sequence.

BH4-dependent synthesis and resource allocation Tryptophan–Serotonin

Tryptophan supplies the TPH route and alternative kynurenine metabolism. It is not downstream of epinephrine. Tryptophan hydroxylase produces 5-HTP, which is then converted to serotonin. Serotonin has separate affect-regulation and SCN-entrainment routes. The SCN route feeds back into Circadian BioDial timing. Serotonin also supplies the melatonin synthesis route below. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand TPH → serotonin → emotional regulation Proposed outcome: emotional dysregulation, depression, anxiety, and recognition/response difficulties.

BH4 Shunt
AAAH Shunt
altered BH4 allocation to tryptophan hydroxylase, TPH
altered tryptophan
5-HTP conversion
altered serotonin synthesis
altered serotonergic modulation of neural circuits involved in affect and behavioral response
emotional recognition and response change
mood regulation changes
emotional dysregulation, depression, anxiety, and recognition/response difficulties.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Tryptophan Hydroxylase; Cognitive Deficits and Emotional Dysregulation. Working reference: Cascade Logic, route K. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand TPH → serotonin → SCN → Circadian BioDial Proposed outcome: sleep timing, circadian regulation, metabolic timing, hormonal timing, and downstream temporal regulation can become dysregulated.

BH4 Shunt
AAAH Shunt
TPH flux changes
serotonin availability changes
serotonergic modulation of retinal input to the suprachiasmatic nucleus, SCN, changes
typical daytime facilitation and nighttime inhibition of photic input changes
SCN entrainment to light changes
circadian synchronization of peripheral clocks changes
circadian protein-synthesis timing changes
sleep timing, circadian regulation, metabolic timing, hormonal timing, and downstream temporal regulation can become dysregulated.

This branch terminates in the Circadian BioDial before producing its secondary downstream phenotypes.

Paper outlining this node: BioToggle and BioDial Categorical Delineation. Section/topic: Introduction: serotonin/SCN entrainment and maternal melatonin/developmental timing. Working reference: Cascade Logic, route L. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Serotonin-derived signaling Melatonin

Serotonin-derived melatonin affects maternal/fetal entrainment and the timing of developmental gene expression and protein production. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: BioToggle and BioDial Categorical Delineation.

Mechanism and source · expand Serotonin → melatonin → fetal/developmental timing Proposed outcome: developmental trajectory differences, depending on which tissue or neural circuit is being constructed during the affected period.

BH4 Shunt
TPH Shunt
serotonin changes
serotonin-derived melatonin changes
maternal/fetal melatonin signaling changes
fetal circadian entrainment changes
timing of developmental gene expression and protein production changes
Developmental BioDial timing changes
neural and systemic developmental programs can occur at altered times
developmental trajectory differences, depending on which tissue or neural circuit is being constructed during the affected period.

Paper outlining this node: BioToggle and BioDial Categorical Delineation. Section/topic: Introduction: serotonin/SCN entrainment and maternal melatonin/developmental timing. Working reference: Cascade Logic, route M. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

NOS · Nitric Oxide Synthase Pathway

NOS · Nitric oxide and redox regulation

These are parallel routes from coupling and redox state, not a synthesis sequence between NOS isoforms.

Vascular / barrier
Mitochondrial
Immune
N3 protein regulation

Additional context · Autism and comorbid traits Pathway-Level Trait Overview

Proposed Trait Connections

Autism-trait connections: The supplied Autism Traits Cascade diagram adds the explicit N3 → mTOR shunt → synaptic-pruning dysregulation → altered circuit refinement/connectivity route. The papers also describe developmental protein routes involving Tenascin-C, VEGF-A/NRP1 and GDNF/RET, including a proposed speech-motor contribution to minimally verbal or nonverbal phenotypes. That speech-motor route is not presented as the explanation for every nonspeaking autistic person.
Comorbid-trait connections: Proposed systemic routes include endothelial/RAAS changes associated with POTS, orthostatic intolerance and dysautonomia; MMP/ECM remodeling associated with hypermobility or hEDS-associated phenotypes; mitochondrial energy impairment; and immune or mucosal/GI effects. Protein-specific auditory and visual developmental routes are retained separately. Some immune/GI links remain incomplete in the source.

Each node is followed by its mechanisms and visible trait or physiological outcomes. Open “Full mechanism and source” for the detailed sequence.

Shared NOS state BH4:BH2 → NOS Coupling

nNOS, eNOS and iNOS are parallel isoforms, not products formed from one another. Usable BH4 relative to BH2 affects coupling and the balance of nitric oxide and superoxide. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities.

Mechanism and source · expand BH4:BH2 → NOS coupling → NO versus superoxide Proposed outcome: sustained oxidative/nitrosative stress.

BH4 Shunt
altered usable BH4 relative to BH2
altered coupling of nNOS, eNOS, and iNOS
when coupled, NOS supports nitric-oxide synthesis
when uncoupled, electron flow shifts toward superoxide
nitric-oxide bioavailability falls while ROS production increases
superoxide interacts with the NO environment
peroxynitrite increases
BH4 is further oxidized toward BH2
BH4:BH2 functional ratio worsens
NOS uncoupling becomes self-reinforcing
sustained oxidative/nitrosative stress.

This redox shift then controls the protein-shunt branches below.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: NOS uncoupling and BH4/BH2 redox regulation. Working reference: Cascade Logic, route U. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Vascular cell and tissue branch eNOS → Endothelial NO

The endothelial route proceeds through vasodilatory signaling, vascular smooth-muscle relaxation, perfusion and autonomic function. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand eNOS → vascular endothelium → vascular tone Proposed outcome: vascular instability and orthostatic/autonomic dysfunction.

BH4 Shunt
NOS Shunt
eNOS coupling changes
endothelial NO synthesis changes
endothelial vasodilatory signaling changes
vascular smooth-muscle relaxation changes
vascular tone and perfusion regulation change
endothelial dysfunction develops
vascular instability and orthostatic/autonomic dysfunction.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Endothelial Dysfunction. Working reference: Cascade Logic, route V. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Barrier physiology branch NO → sGC → cGMP

The source proposes a medication-penetration route through soluble guanylyl cyclase, cGMP and blood-brain-barrier tight-junction regulation. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand NOS/NO → guanylyl cyclase → cGMP → BBB permeability → medication resistance Proposed outcome: medication resistance / reduced drug penetration in the mechanism proposed in the older paper.

BH4 Shunt
NOS Shunt
decreased NO synthesis
reduced stimulation of soluble guanylyl cyclase
reduced cGMP
reduced tight-junction rearrangement at the blood-brain barrier
altered Claudin-5 mediated barrier permeability
BBB remains relatively restrictive
CNS penetration of some medications may decrease
medication resistance / reduced drug penetration in the mechanism proposed in the older paper.

The same source links increased intracellular/brain Ca²⁺ and overactivity of the mitochondrial aspartate/glutamate carrier, AGC, to worsened cellular metabolism and oxidative stress, which can further amplify excitotoxicity.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Medication Resistance. Working reference: Cascade Logic, route X. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Cellular energy branch ROS/RNS → Mitochondrial Function

The redox route follows protein and membrane damage into reduced mitochondrial function, energy output and tissue vulnerability. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand NOS/redox → mitochondrial function Proposed outcome: energy deficits, fatigue-related physiology, worsened neural dysfunction, and metabolic impairment.

NOS uncoupling
superoxide/peroxynitrite increase
protein oxidation and lipid peroxidation increase
mitochondrial proteins and membranes are damaged
mitochondrial function decreases
ATP/energy production declines
cellular metabolism becomes less efficient
neurons and other high-energy-demand tissues become more vulnerable
energy deficits, fatigue-related physiology, worsened neural dysfunction, and metabolic impairment.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Consequences of Oxidative Stress and Superoxide Production; Mitochondrial dysfunction. Working reference: Cascade Logic, route Y. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Immune cell and mucosal branches iNOS and Immune BH4 Demand

Cytokine/GCH1/iNOS signaling and T-cell/IL-17-associated mucosal demand are separate immune routes. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway.

Mechanism and source · expand Immune activation → GCH1/BH4 → iNOS → inflammatory physiology Proposed outcome: immune dysfunction, inflammatory dysregulation, autoimmune/allergic inflammatory phenotypes can emerge when activation becomes persistent.

PAMP or immune-system activation
cytokine signaling
induction of GCH1
increased BH4 demand
altered support of iNOS
nitric-oxide and redox signaling in activated immune cells changes
inflammatory-response intensity and resolution change
immune-regulatory state changes
immune dysfunction, inflammatory dysregulation, autoimmune/allergic inflammatory phenotypes can emerge when activation becomes persistent.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Autoimmune Diseases; GI Comorbidities; Cytokines. Working reference: Cascade Logic, route AI. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand Immune BH4 → T-cell / IL-17 related branch → GI and inflammatory phenotype Proposed outcome: gastrointestinal inflammation, gastrointestinal disorders, immune-mediated GI symptoms, autoimmune/inflammatory comorbidity.

Immune BioToggle activation
T-cell metabolic activation
BH4-dependent immune metabolic demand changes
altered pro-inflammatory T-cell signaling, including the IL-17/TH17 axis discussed in the source set
mucosal inflammatory signaling changes
intestinal immune regulation changes
gastrointestinal inflammation, gastrointestinal disorders, immune-mediated GI symptoms, autoimmune/inflammatory comorbidity.

The older papers develop this as an immune/GI association and mechanistic proposal rather than a fully closed molecular chain for every GI phenotype.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Autoimmune Diseases; GI Comorbidities; Cytokines. Working reference: Cascade Logic, route AJ. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

N3 · Epigenetic Redox-Sensitive Protein Shunts

BioToggle demand and BioDial timing determine which proteins are induced. Redox state changes their functional behavior. Each mechanism and its proposed trait or physiological outcome is visible below; expand only for the complete route and source.

Mechanism

mTOR shunt → synaptic pruning → circuit refinement

Autism-trait prediction · Supplied diagram mTOR Shunt · Synaptic Pruning and Neural Connectivity

NOS shunt
epigenetic redox-sensitive protein shunts
mTOR shunt
dysregulated synaptic pruning
altered circuit refinement and connectivity patterns
proposed neural-connectivity traits

This is the proposed route shown in the supplied Autism Traits Cascade diagram. The diagram does not specify a uniform direction of mTOR activity or establish each causal link in individuals.

Source: supplied Autism Traits Cascade diagram (IMG_1909).

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory.

Proposed autism-trait connection

Altered neural connectivity patterns. This prediction comes from the supplied Autism Traits Cascade diagram.

Mechanism and source · expand Sympathetic tone → RAAS → ACE2 → POTS Proposed outcome: exaggerated orthostatic tachycardia, orthostatic intolerance, autonomic instability, dysautonomia, POTS.

Nervous System BioToggle / sympathetic activation
norepinephrine-mediated sympathetic tone increases
β1-adrenergic stimulation of renal juxtaglomerular cells
renin release changes
RAAS activity changes
Angiotensin II increases or persists
Ang II drives vasoconstrictive and pro-oxidant signaling
ACE2 activity becomes relatively reduced
conversion of Ang II to Angiotensin-(1-7) decreases
Mas receptor mediated vasodilatory, antioxidant, and anti-inflammatory signaling decreases
Ang II clearance falls
vascular oxidative burden rises
vascular tone and blood-volume regulation become less stable
compensatory sympathetic activity increases
heart-rate compensation on standing increases
exaggerated orthostatic tachycardia, orthostatic intolerance, autonomic instability, dysautonomia, POTS.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory. Section/topic: ACE2 Shunt: sympathetic activation, renin and orthostatic physiology. Working reference: Cascade Logic, route W. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism

hEDS · MMP Shunts and Connective-Tissue Remodeling

NOS/redox changes and cellular repair activity affect MMP-mediated collagen and extracellular-matrix remodeling, alongside Tenascin-C signaling and isoform susceptibility.

Collagen, matrix remodeling and Tenascin-C Full MMP / hEDS mechanisms and sources

NOS + Cellular Repair BioToggle → hEDS cascade

BH4 Shunt
NOS uncoupling
oxidative/redox shift
redox-sensitive Cellular Repair protein induction
Tenascin-C and MMP programs change
fibrillar collagen and ECM substrates are excessively remodeled
connective-tissue structural integrity declines
hypermobility / hEDS-associated phenotype.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: hE-DS: Tenascin-C, MMPs and extracellular-matrix remodeling. Working reference: Cascade Logic, route AT. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Proposed outcome: hypermobility / hEDS-associated phenotype.

NOS/redox → MMP-1 → fibrillar collagen → hEDS phenotype

BH4 Shunt
NOS Shunt
ROS/RNS/redox shift
redox-sensitive regulation of MMP-1
MMP-1 cleavage of type I, II, and III fibrillar collagen
collagen triple helices are disrupted
cleaved collagen becomes more susceptible to secondary proteases
ECM proteolysis increases
collagen organization and mechanical integrity decline
connective tissues become less structurally stable
joint/tissue laxity, hypermobility, hEDS-associated connective-tissue phenotype.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: hE-DS: Tenascin-C, MMPs and extracellular-matrix remodeling. Working reference: Cascade Logic, route Z. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Proposed outcome: joint/tissue laxity, hypermobility, hEDS-associated connective-tissue phenotype.

NOS/redox → MMP-2 / MMP-9 → basement membrane / gelatin

Redox shift
altered MMP-2 and MMP-9 expression/activity
altered degradation of gelatin, denatured collagen, and basement-membrane substrates
extracellular matrix turnover changes
angiogenic, neurogenic, and tissue-repair scaffolding changes
vascular remodeling, neurodevelopmental remodeling, and connective-tissue integrity can be altered.

The source does not assign every MMP-2/MMP-9 change to one unique outward trait, so the website should stop at those tissue-level consequences unless a specific branch is supported elsewhere.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: hE-DS: Tenascin-C, MMPs and extracellular-matrix remodeling. Working reference: Cascade Logic, route AA. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Proposed outcome: vascular remodeling, neurodevelopmental remodeling, and connective-tissue integrity can be altered.

NOS/redox → Tenascin-C → TLR4 / α9-integrin → inflammatory ECM remodeling

Cellular Repair BioToggle activation
redox-sensitive Tenascin-C induction and isoform state change
Tenascin-C engages TLR4
cytokine production increases
Tenascin-C engages α9-integrin
cytokine and MMP expression increases
inflammatory ECM-remodeling program is reinforced
matrix degradation/remodeling persists
tissue repair becomes chronically activated
persistent inflammatory remodeling and reduced connective-tissue integrity.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: hE-DS: Tenascin-C, MMPs and extracellular-matrix remodeling. Working reference: Cascade Logic, route AB. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Proposed outcome: persistent inflammatory remodeling and reduced connective-tissue integrity.

Tenascin-C isoform → MMP susceptibility → ECM structure

Epigenetic/genetic protein-synthesis shift
alternative splicing of Tenascin-C
large versus small Tenascin-C isoform abundance changes
large isoform exposes additional type III repeats and protease-sensitive regions
susceptibility to MMP-2, MMP-3, MMP-7 changes
ECM degradation pattern changes
matrix architecture changes
connective-tissue remodeling phenotype.

This is a direct example of a BioToggle-controlled protein isoform changing the downstream tissue substrate.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: hE-DS: Tenascin-C, MMPs and extracellular-matrix remodeling. Working reference: Cascade Logic, route AC. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Proposed outcome: connective-tissue remodeling phenotype.

Proposed trait / physiological outcome

Reduced connective-tissue integrity, joint/tissue laxity and hypermobility in the model’s hEDS-associated pathway. MMP-2/MMP-9 routes also describe tissue-remodeling effects, not an exclusive or independently diagnostic hEDS outcome.

Mechanism and source · expand Developmental redox → Tenascin-C → VEGF-A → NRP1 → facial motor neuron migration Proposed outcome: facial hypotonia, atypical facial expression, impaired articulation, impaired oral-motor control, minimally verbal or nonverbal speech output in the proposed subtype. Proposed additional connection: reduced facial expressivity (sometimes described as flat affect), reflecting facial motor output rather than internal emotional experience.

Developmental BioDial
Nervous System / Cellular Repair / Epigenetic BioToggle demand
BH4 Shunt
NOS/redox state
altered redox-sensitive developmental protein regulation
Tenascin-C signaling changes
VEGF-A expression/signaling changes
VEGF-A binding to neuropilin-1, NRP1
altered axon guidance and cell-body migration of developing facial motor neurons
altered migration from rhombomere 4 toward rhombomeres 5 and 6
altered formation/organization of the facial motor nucleus
altered innervation of second branchial-arch-derived facial musculature
altered muscular control of facial expression, articulation, and oral-motor movement
facial hypotonia, atypical facial expression, impaired articulation, impaired oral-motor control, minimally verbal or nonverbal speech output in the proposed subtype.

Proposed facial-expression connection: altered facial motor-neuron axon guidance, migration and target-muscle innervation may reduce the range or control of facial movement. The model links this to reduced facial expressivity, sometimes described as flat affect. This is a proposed motor explanation for outward expression, not evidence of reduced emotion, empathy or social understanding. The paper discusses facial motor control; the flat-affect label is the author’s added trait connection here.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: Nonverbality and Motor Neurons Involved in Speech; developmental VEGF/NRP1 and GDNF/RET routes. Working reference: Cascade Logic, route AD. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand Developmental redox → GDNF → RET → presynaptic neuromuscular maturation Proposed outcome: oral-motor dysfunction, articulation impairment, facial-motor differences, minimally verbal/nonverbal phenotype.

Developmental BioDial
redox-sensitive developmental protein shunt
altered GDNF
altered signaling through RET on motor neurons
impaired or altered presynaptic specialization at neuromuscular terminals
altered target-muscle innervation
altered neuromuscular transmission to facial/oral musculature
reduced precision of speech-motor output
oral-motor dysfunction, articulation impairment, facial-motor differences, minimally verbal/nonverbal phenotype.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: Nonverbality and Motor Neurons Involved in Speech; developmental VEGF/NRP1 and GDNF/RET routes. Working reference: Cascade Logic, route AE. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand Oxidative stress → HO-1 → GDNF/BDNF stress allocation Proposed outcome: speech-motor impairment / nonverbal phenotype.

NOS/redox shift
oxidative stress
induction of heme oxygenase-1, HO-1
production of bilirubin and carbon monoxide
activation of ERK, PI3K/Akt, and sGC-PKG
increased GDNF/BDNF stress-resilience signaling
model predicts that sustained oxidative demand may functionally recruit GDNF toward antioxidant/resilience functions
less effective GDNF/RET developmental signaling may remain available for canonical motor-neuron maturation
facial/oral motor development may be affected
speech-motor impairment / nonverbal phenotype.

The newer paper treats the “GDNF diversion” step as a proposed mechanism requiring additional direct testing, so it should be marked as such on the website.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: Nonverbality and Motor Neurons Involved in Speech; developmental VEGF/NRP1 and GDNF/RET routes. Working reference: Cascade Logic, route AF. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand VEGF-A/NRP1 → cochlea / auditory pathway Proposed outcome: hearing impairment / auditory developmental differences where this branch is affected.

Developmental redox-sensitive signaling
VEGF-A/NRP1 activity changes
cochlear vascularization changes
cochlear structural development changes
spiral ganglion neuron pathfinding changes
auditory axon guidance and connectivity change
auditory-system function changes
hearing impairment / auditory developmental differences where this branch is affected.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: Nonverbality and Motor Neurons Involved in Speech; developmental VEGF/NRP1 and GDNF/RET routes. Working reference: Cascade Logic, route AG. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand VEGF-A/NRP1 → retina / visual pathway Proposed outcome: visual developmental differences / altered visual function where this branch is affected.

Developmental redox-sensitive signaling
VEGF-A/NRP1 activity changes
retinal vascular development changes
retinal patterning changes
visual-pathway connectivity changes
visual-system development changes
visual developmental differences / altered visual function where this branch is affected.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: Nonverbality and Motor Neurons Involved in Speech; developmental VEGF/NRP1 and GDNF/RET routes. Working reference: Cascade Logic, route AH. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

AGMO · Alkylglycerol Monooxygenase Pathway

AGMO · Ether-lipid metabolism

Ether-lipid handling branches into distinct cellular and systemic effects.

Membranes
Endocannabinoids
Inflammatory lipids
Systemic lipid profile

Additional context · Autism and comorbid traits Pathway-Level Trait Overview

Proposed Trait Connections

Autism-trait connections: The supplied Autism Traits Cascade diagram proposes ether-lipid catabolism/lipid reorganization → altered endocannabinoid signaling, microglial activity and social-regulatory pathways → social-interaction or social-avoidance traits. This adds an explicit trait prediction to the earlier paper-derived membrane-development route, which did not assign one unique outward trait.
Comorbid-trait connections: The supplied Comorbid Traits Cascade diagram links lipid reorganization and endocannabinoid signaling to stress regulation, adaptation and recovery. The paper-derived branches additionally describe inflammatory lipid signaling and systemic lipid-profile changes, with their stated biomarker and final-trait gaps retained.

Each node is followed by its mechanisms and visible trait or physiological outcomes. Open “Full mechanism and source” for the detailed sequence.

BH4-dependent enzyme and substrate pool AGMO → Ether-Lipid Catabolism

AGMO-mediated ether-lipid catabolism affects the lipid environment in which membrane proteins and signaling complexes operate. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities.

Mechanism and source · expand AGMO → ether lipids → cellular membrane architecture Proposed outcome: downstream neural developmental/function traits depend on the affected cell population and developmental window.

BH4 Shunt
altered BH4 allocation to alkylglycerol monooxygenase, AGMO
altered catabolism of membrane glycerol ether lipids
ether-lipid pools change
plasmalogen / plasmanyl / plasmenyl related membrane composition changes
membrane fluidity changes
membrane-protein organization changes
lipid-raft signaling changes
receptor and signaling-complex organization changes
vesicle trafficking changes
synaptic and cellular communication environments change
dendritic plasticity, myelination, and synaptic reorganization can be altered
downstream neural developmental/function traits depend on the affected cell population and developmental window.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: AGMO shunt and ether-lipid metabolism. Working reference: Cascade Logic, route AK. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Cellular and synaptic branch Membrane Architecture

The route continues through receptor localization, vesicle trafficking, dendritic remodeling and neural plasticity. The source does not assign every lipid change to a unique autism trait. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities.

Mechanism and source · expand AGMO → ether-lipid membrane environment → synaptic remodeling Proposed outcome: learning, sensory, reward, communication, or motor traits may change only where the specific circuit is demonstrated to depend on this altered lipid environment.

AGMO Shunt
altered ether-lipid catabolism
membrane architecture changes in neural cells
vesicle formation and trafficking change
receptor localization and lipid-raft signaling change
synaptic membrane dynamics change
dendritic remodeling and synaptic reorganization change
circuit plasticity changes
learning, sensory, reward, communication, or motor traits may change only where the specific circuit is demonstrated to depend on this altered lipid environment.

The cited papers stop before assigning individual AGMO lipid changes to each outward autism trait, so the website should not fabricate a one-to-one mapping.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: AGMO shunt and ether-lipid metabolism. Working reference: Cascade Logic, route AL. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Lipid-signaling branch Noladin Ether → Endocannabinoid Environment

The source describes the relationship to 2-AG and cannabinoid modulation while retaining an unresolved final trait assignment. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities.

Mechanism and source · expand AGMO → noladin ether → 2-AG → endocannabinoid signaling Proposed outcome: altered endocannabinoid-mediated brain function and stress regulation.

BH4 Shunt
AGMO Shunt
altered metabolism of 2-arachidonoylglycerol ether, noladin ether
altered relationship to 2-arachidonoylglycerol, 2-AG
altered endocannabinoid signaling
altered cannabinoid-receptor modulation of synaptic transmission and stress signaling
neural and stress-response signaling changes
altered endocannabinoid-mediated brain function and stress regulation.

The source does not yet specify a fully demonstrated final outward trait for each 2-AG change, so this branch should end at the supported physiological level.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: AGMO shunt and ether-lipid metabolism. Working reference: Cascade Logic, route AM. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Inflammatory lipid branch PAF

Altered inflammatory ether-lipid handling connects AGMO activity to immune cells and inflammatory tissues. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities.

Mechanism and source · expand AGMO → PAF → inflammatory lipid signaling Proposed outcome: immune/inflammatory phenotype.

BH4 Shunt
AGMO Shunt
altered metabolism of platelet-activating factor, PAF
altered inflammatory ether-lipid signaling
altered activation/signaling in immune cells and inflammatory tissues
inflammatory response changes
immune/inflammatory phenotype.

Again, the source supports the inflammatory signaling bridge more strongly than one specific final diagnosis.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: AGMO shunt and ether-lipid metabolism. Working reference: Cascade Logic, route AN. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Metabolic phenotype branch Systemic Lipid Profile

The lipid-profile route is separate from membrane and endocannabinoid signaling and retains the stated biomarker gap. In the model, this node is not inherently a deficit: local availability or functional activity can be higher or lower as resources are reallocated according to biological demand, location and timing.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities.

Mechanism and source · expand AGMO → systemic ether-lipid profile → dyslipidemia Proposed outcome: dyslipidemia.

BH4 Shunt
AGMO Shunt
altered ether-lipid catabolism
altered plasmanyl/plasmenyl and related lipid pools
altered systemic lipid profile
dyslipidemia.

The newer BH4 paper explicitly notes increased dyslipidemia in autism and altered endocannabinoid findings, but also states that direct plasmanyl/plasmenyl biomarker studies in autistic cohorts remain lacking.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: AGMO shunt and ether-lipid metabolism. Working reference: Cascade Logic, route AO. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Autism and Comorbid-Trait Clusters

Use the table to compare the five domains. Below it, expand the autism cluster or one of the four comorbid domains, then follow their interconnections and cumulative effects over time.

Trait outcomes emerge through BioToggle and BioDial interaction

In the model, trait outcomes reflect how each regulatory system domain is affected through patterns of function, development and wear/load.

Immune BioToggle

Function: Circadian rhythm + circannual cycles
Development: Immune development patterns
Wear + load: Accumulated immune burden

Metabolic BioToggle

Function: Circadian rhythm + circannual cycles
Development: Metabolic development patterns
Wear + load: Accumulated metabolic burden

Cellular Repair BioToggle

Function: Circadian rhythm + circannual cycles
Development: Repair and remodeling patterns
Wear + load: Accumulated cellular stress

Nervous System BioToggle

Function: Circadian rhythm + circannual cycles
Development: Neural circuit development → skills and behaviors
Wear + load: Nervous-system load accumulation

Genetic Regulation BioToggle

Function: Circadian rhythm + circannual cycles
Development: Gene-regulation development patterns
Wear + load: Regulatory strain over time

Extent of impact depends on timing and duration

When in the lifespan

Ultradian, circadian, circannual, developmental stage and age shape how and where the impact is expressed.

Duration and conditions of activation

Genetically Locked, Epigenetically Stuck or Situationally Flipped activation shapes persistence. Duration, strength, individual entry point and cumulative load influence the extent of impact.

Autism-cluster traits and comorbid traits

Autism-cluster traits: impacts on development and function within the nervous system domain. These include neural-circuit development through E/I imbalance and mTOR signaling differences, and circuit function through neurotransmitter imbalance in CSTL circuitry.

Comorbid traits: impacts on function, development and wear/load across the other four interconnected domains: immune, metabolic, cellular repair and genetic regulation.

This is the model’s outcome classification, not a separation into independent biological systems. The domains interact, and higher or lower local activity depends on where resources are reallocated to meet demand.

Nervous-system development and function Autism-Trait Cluster · Nervous System and BH4 Diversion

BH4 diversion under nervous-system domain activation: in the model, nervous-system regulatory demand participates in the shared reallocation of BH4-dependent and downstream biochemical resources. AAAH, NOS and AGMO shunts alter neural development and function according to local demand, available resources and developmental timing. This does not require every person to enter the Cascade at the same upstream node.

Domain classification: nervous-system development and function. In the model, the BH4 shunt affects neural-circuit development through E/I imbalance and mTOR signaling differences, and circuit function through neurotransmitter imbalance in CSTL circuitry.

AAAH / CSTL: altered excitation, inhibition and neurotransmitter availability affect the development and expression of skills and behaviors. The proposed outcomes include differences in movement, habits, reward-related behavior and skill development, with regression where circuit damage affects previously acquired functions.
NOS / redox-sensitive proteins / mTOR: changes in synaptic pruning and circuit refinement contribute to the proposed neural-connectivity traits.
AGMO / lipid signaling: altered endocannabinoid signaling, microglial activity and social-regulatory pathways contribute to the proposed social-interaction and social-avoidance traits.

Which circuits are affected, when they develop and how they function determine the trait pattern. Not every autistic person is predicted to have every trait or the same direction of difference.

Model sources: Autism & the Comorbidities Along the BH4 Pathway; The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities; Neurodivergent Biochemistry and the Autism and the Comorbidities Theory. Branch classification follows the supplied Autism Traits Cascade diagram.

Specific nervous-system mechanisms and trait connections

Autism-trait mechanism · expand E/I imbalance in CSTL: movement, habit formation and reward

Proposed shunt-to-circuit route: BH4 / AAAH shunting redirects precursor use and alters glutamate allocation, GABA balance and catecholamine signaling. The resulting excitation/inhibition imbalance changes the development and function of cortico-striatal-thalamo-limbic (CSTL) circuits. Movement: altered circuit activation and inhibition affect motor control, coordination and the expression of movement patterns. Habit formation: altered circuit formation and activity affect acquisition, repetition and expression of learned skills and behaviors. Reward: altered circuit signaling affects reward processing and reinforcement of behavior. In the model, these are direct mechanisms contributing to the autism-trait cluster, alongside the oxytocin-sensitive social-circuit route, not merely secondary effects of social differences. Local resource allocation and circuit state determine whether activity is increased or reduced. These functional differences do not require excitotoxic damage; the damage-to-regression route is described separately below.

Model sources: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities, AAAH/transamination and CSTL discussion; Autism & the Comorbidities Along the BH4 Pathway, dopamine, motor control and cortico-striatal-thalamic circuitry discussions; supplied Autism Traits Cascade diagram.

Glutamate / GABA and CSTL route · CSTL hyperactivity and hypoactivity route

Autism-trait mechanism · expand E/I imbalance and oxytocin-sensitive circuitry

The model links glutamate dysregulation and excessive excitation to excitotoxic impairment or damage of oxytocin-receptor-expressing glutamatergic neurons in the prefrontal cortex. Altered signaling in oxytocin-sensitive PFC–amygdala circuitry is then linked to differences in social recognition, social memory, social cognition and social behavior. This is an effect on receptor-bearing neurons and circuit function, not simply a claim that all oxytocin receptors or oxytocin levels decrease.

Autism-trait mechanism · expand Excitotoxicity and regression

Where excessive excitation produces excitotoxic damage to circuits supporting previously acquired skills or behaviors, the model proposes deterioration of circuit function and regression. E/I imbalance does not automatically imply excitotoxicity, and this proposed route is not presented as the cause of every instance of regression.

Autism-trait mechanism · expand Facial motor-neuron guidance and flat affect

The developmental route follows Tenascin-C → VEGF-A → NRP1 signaling into facial motor-neuron axon guidance and migration, then facial-muscle innervation and motor control. The model connects altered development to reduced facial expressivity, sometimes described as flat affect, alongside oral-motor and articulation differences. Reduced visible expression is not equivalent to reduced emotional experience, empathy or understanding.

Oxytocin-sensitive circuitry and excitotoxicity: Autism & the Comorbidities Along the BH4 Pathway, Low Oxytocin, Autism Social Symptoms and glutamate discussions. Facial motor development: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities, Nonverbality and Motor Neurons Involved in Speech. Regression and the flat-affect wording are presented here as the model’s proposed trait connections.

Oxytocin-sensitive circuit route · Excitotoxicity and regression route · Facial motor-neuron route

Node-to-trait routes

Mechanism and source · expand AAAH + NOS → glutamate excitotoxicity → neuronal injury Proposed outcome: depending on location, motor, cognitive, social, emotional, or medication-response differences can emerge. The model also proposes excitotoxicity-induced regression when damage impairs circuits supporting previously acquired skills or behaviors.

BH4 Shunt
AAAH resources shift toward transamination
glutamate increases or becomes poorly regulated
+
NOS Shunt
NO decreases / oxidative stress increases
+
KYNA reduction where present
glutamate-receptor inhibition decreases
excessive glutamate receptor activation
intracellular Ca²⁺ rises
excitotoxicity increases
neuronal damage or death
circuit function deteriorates
depending on location, motor, cognitive, social, emotional, or medication-response differences can emerge.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: The Domino Effect of BH4 Pathway Dysfunction on Neurotransmitter Metabolism and Brain Circuitry. Working reference: Cascade Logic, route AP. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand AAAH + NOS → CST loop → hyperactivity versus hypoactivity Proposed outcome: hyperactivity, motor differences, cognitive suppression, hypoactivity, or impaired movement control, depending on direction.

BH4 Shunt
dopamine imbalance
+
glutamate/KYNA imbalance
+
redox/mitochondrial stress
direct and indirect CST pathway balance changes
excitatory drive can increase or decrease
CST loop becomes hyperexcitable or hypoactive
hyperactivity, motor differences, cognitive suppression, hypoactivity, or impaired movement control, depending on direction.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: The Domino Effect of BH4 Pathway Dysfunction on Neurotransmitter Metabolism and Brain Circuitry. Working reference: Cascade Logic, route AQ. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand AAAH + NOS → social circuit Proposed outcome: impaired social recognition, social cognition, social memory, and social behavior.

BH4 Shunt
AAAH/transamination shift
glutamate dysregulation
+
NOS dysfunction
free-radical burden increases
OXTR-expressing glutamatergic PFC neurons become vulnerable
PFC-amygdala social-recognition circuit signaling decreases
oxytocin-mediated social processing declines
impaired social recognition, social cognition, social memory, and social behavior.

Paper outlining this node: Autism & the Comorbidities Along the BH4 Pathway. Section/topic: Autism Social Symptoms; oxidative stress and oxytocin-sensitive circuitry. Working reference: Cascade Logic, route AR. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Mechanism and source · expand NOS + Developmental BioDial → speech-motor cascade Proposed outcome: minimally verbal or nonverbal phenotype. Proposed additional connection: reduced facial expressivity (sometimes described as flat affect), reflecting facial motor output rather than internal emotional experience.

BH4 Shunt
NOS/redox shift during a Developmental BioDial
developmental protein shunting
Tenascin-C / VEGF-A / NRP1 and GDNF / RET signaling changes
facial motor neuron migration, axon guidance, survival, target innervation, or presynaptic specialization changes
facial/oral neuromuscular circuitry develops atypically
articulation and speech-motor control change
minimally verbal or nonverbal phenotype.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: Nonverbality and Motor Neurons Involved in Speech; developmental VEGF/NRP1 and GDNF/RET routes. Working reference: Cascade Logic, route AU. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Comorbid-Trait Clusters · The Other Four Domains

Explore how each domain’s activation and resource priorities shape its proposed effects on function, development and cumulative wear. Each works with the other domains rather than producing an isolated set of traits.

Interconnected comorbid domain Immune System · Comorbid-Trait Clusters

Activation: Pathogens, PAMPs and antigen signaling initiate immune demand. Unresolved triggers or genetically impaired resolution can sustain it.

Shunt and resource allocation: Resources and protein production are prioritized toward immune defense. In the model, BH4-associated redox and downstream protein shunts alter inflammatory signaling and the balance between activation and resolution.

Proposed comorbid outcomes: The paper discusses cytokine signaling, immune differences and gastrointestinal comorbidities. These are connected through interacting immune and tissue functions, not assigned exclusively to the immune system.

Example: PAMP recognition can recruit cytokine production, inflammatory cells and immune protein synthesis together. If the demand persists, multiple functions can be affected by the same sustained response.

Timing and persistence: the same domain can be affected in ongoing function, development and accumulated wear. Activation conditions, developmental stage, duration, strength and interactions with the other domains shape which traits occur together.

Model sources: Autism & the Comorbidities Along the BH4 Pathway; BioToggle and BioDial Categorical Delineation.

Interconnected comorbid domain Metabolic System · Comorbid-Trait Clusters

Activation: Nutrient shifts, energy demand or altered nutrient/energy sensing initiate metabolic regulation.

Shunt and resource allocation: Substrates, cofactors and protein activity are redistributed between energy production, antioxidant demand and other functions. Higher use in one pathway can coexist with lower availability elsewhere.

Proposed comorbid outcomes: The model connects energy balance, mitochondrial function, amino-acid allocation and lipid handling to systemic metabolic effects. Specific outcomes depend on the affected tissue and pathway, not a single metabolic deficit.

Example: AAAH-associated precursor diversion toward transamination can change glutamate production and allocation between antioxidant support, GABA synthesis and signaling. This illustrates how a metabolic demand can also affect nervous-system function.

Model sources: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities; Autism & the Comorbidities Along the BH4 Pathway.

Interconnected comorbid domain Cellular Repair · Comorbid-Trait Clusters

Activation: Mechanical damage, tissue injury and DAMPs activate repair. Persistent damage or genetically impaired repair can maintain demand.

Shunt and resource allocation: Redox-sensitive protein regulation changes repair activity, extracellular-matrix turnover and structural protein availability. Tenascin-C signaling and isoform state interact with MMP-mediated substrate remodeling.

Proposed comorbid outcomes: The model’s hEDS-associated route links altered collagen and matrix remodeling to reduced connective-tissue integrity, laxity and hypermobility. Activation of repair alone does not establish hEDS.

Example: The combined MMP node traces distinct collagen and matrix substrates within one repair-related route. The proposed trait cluster reflects shared changes in tissue structure, rather than a separate unrelated cause for each joint or tissue effect.

Model sources: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities; BioToggle and BioDial Categorical Delineation.

Explore the combined hEDS / MMP shunt node

Interconnected comorbid domain Genetic Regulation / Protein Synthesis · Comorbid-Trait Clusters

Activation: Cellular stress and ongoing physiological needs regulate gene expression and protein production. Genetically altered synthesis or function can constrain the response.

Shunt and resource allocation: Changes in transcription, alternative splicing, isoform production and protein function alter which molecules are available to other regulatory domains. BioDial timing determines when those products are needed.

Proposed comorbid outcomes: Effects occur through the functions of the affected proteins across immune, metabolic and repair systems. This domain is not assigned a single unique outward comorbidity; its downstream protein routes determine the trait pattern.

Example: Different Tenascin-C isoforms have different susceptibility to proteases. A change in isoform production can therefore change matrix remodeling even when the same protein family is involved, linking genetic regulation with cellular repair.

Model sources: Genomic and Proteomic Regulation in Cellular Homeostasis; The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities; BioToggle and BioDial Categorical Delineation.

How the Five Domains Are Interconnected

The five domains share resources and affect one another through biochemical pathways and feedback. Their outcome categories do not make them independent systems. An immune or repair demand can change metabolism and protein production, while altered resource availability can affect nervous-system development and function.

One shared process: regulatory activation changes resource allocation; BioDial timing changes which functions need those resources at that moment. Local availability and activity can rise or fall. Their combination, not a fixed list of deficits, shapes the individual trait cluster.

Detailed connections and source routes Examples of Shared Resources, Timing and Cross-System Effects

In the model, autism traits and comorbid traits are parallel outcomes of an interconnected regulatory and temporal system. BioToggle activation reallocates biochemical resources toward the stress response. BH4-associated shunting and redox-sensitive changes in protein function alter downstream pathways while disrupting BioDial-regulated protein production. Traits cluster because these shared changes affect several functions together.

The regulatory and temporal sections below examine the same process from two perspectives: which response receives resources, and when those resources and proteins are needed elsewhere. Individual entry point, Genetically Locked / Epigenetically Stuck / Situationally Flipped activation, key developmental stages, duration and strength shape the outcome. These variables are not equally weighted, and not every autistic person has every trait.

Shunts, not a uniform deficit: each node can have higher or lower local availability or activity in the model, depending on where resources are allocated to meet demand at that time. Increased use in one pathway can coexist with reduced availability in another. Trait clusters depend on this distribution across interconnected systems, not simply a whole-body measurement being high or low.

3. Comorbid-Trait Clusters · Temporal System Domain Disruption

When are the redirected proteins and resources needed? BioDials regulate the temporal flow of protein synthesis for development, ongoing function and repair. The paper proposes that BioToggle activation prioritizes survival-related production, disrupting this flow. Several functions can therefore be affected together because they require coordinated protein availability during the same period.

Document-based example Example · Serotonin, SCN timing and developmental coordination

The paper describes serotonin modulating SCN input, and maternal melatonin helping entrain fetal rhythms during gestation. In the model, disruption of this coordination affects the timing context in which developmental proteins are needed. The proposed clustering mechanism is disrupted coordination of concurrent developmental processes, not a claim that a serotonin change inevitably produces a particular combination of traits.

Document-based example Example · Shared developmental resources and motor functions

The allostatic paper traces VEGF-A/NRP1 and GDNF/RET relationships in motor-neuron development in its discussion of nonverbality. This illustrates why the developmental window matters: disruption of proteins needed for motor-neuron formation can affect the physiological functions those neurons support, rather than being solely a social or behavioral difference. The paper’s proposed HO-1/GDNF diversion remains explicitly unresolved.

One integrated explanation: the regulatory domain identifies the demand competing for resources; the developmental BioDial identifies which forming circuits and tissues need those resources at that time. Duration and strength change the extent of the proposed downstream effects.

Sources: BioToggle and BioDial Categorical Delineation, Introduction and Step 6; The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities, Nonverbality and Motor Neurons Involved in Speech.

Mechanism and source · expand AAAH + NOS → autonomic POTS cascade Proposed outcome: POTS / orthostatic intolerance / dysautonomia.

BH4 Shunt
catecholamine imbalance
norepinephrine/sympathetic activation changes
RAAS activation changes
+
NOS/eNOS redox dysfunction
endothelial NO decreases
Ang II/ACE2 redox imbalance increases
vasodilatory reserve decreases
orthostatic compensation becomes inefficient
heart-rate compensation increases
POTS / orthostatic intolerance / dysautonomia.

Paper outlining this node: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory. Section/topic: ACE2 Shunt: sympathetic activation, renin and orthostatic physiology. Working reference: Cascade Logic, route AS. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

hEDS: view the combined MMP and connective-tissue remodeling node. This node brings together the NOS, cellular repair, Tenascin-C and MMP routes.

Mechanism and source · expand AGMO + Developmental BioDial → neural membrane-development cascade Proposed outcome: developmental neural-function differences.

BH4 Shunt
AGMO Shunt
ether-lipid metabolism changes during neural development
neuronal membrane architecture changes
vesicle trafficking, lipid-raft signaling, myelination, dendritic plasticity, and synaptic reorganization change
neural circuit maturation changes
developmental neural-function differences.

The papers do not yet assign this pathway to one unique outward autism trait, so it should remain at the neural-development level unless later source material closes the branch.

Paper outlining this node: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities. Section/topic: AGMO shunt and ether-lipid metabolism. Working reference: Cascade Logic, route AV. The sequence is presented as the model’s proposed explanation, not proof that every connecting step is established.

Allostatic Overload and Cumulative Progressive Conditions

What happens when restoration does not occur? The categorical delineation table distinguishes a situational response from unresolved chronic activation and genetically locked impairment. Persistent demand maintains stress-related resource allocation instead of fully restoring typical development, maintenance and function. The model links the cumulative physiological cost to allostatic load and, when demand exceeds adaptive capacity, overload.

Persistent or repeated regulatory demand
continuing resource reallocation and disruption of timed protein production
cumulative allostatic load
demand exceeds adaptive capacity
allostatic overload and physiological wear
reduced functional reserve and vulnerability to chronic progressive conditions

Document-based example Example · Unresolved repair versus completed repair

A situational injury engages repair and can resolve when tissue repair is completed and inflammation subsides. The paper’s chronic category instead describes persistent, unresolved repair activity. In the model, continued demand and disrupted maintenance accumulate effects over time. The affected tissues, duration, strength and remaining capacity determine the proposed progressive pattern, rather than a single episode predicting a chronic condition.

This cumulative process is distinct from disruption during a specific developmental window, although both can occur in the same person. Progression is not inevitable for every autistic person.

Sources: BioToggle and BioDial Categorical Delineation, Table 1, Introduction and Step 6; Neurodivergent Biochemistry and the Autism and the Comorbidities Theory, discussion of persistent regulatory activation and systemic effects.

Linked original publications Kitzerow’s Papers

Click to access the ResearchGate Page

Node-level links identify

Next Step

Where to Start

Choose the path that matches what you are looking for.

Researchers